Rebalix
Vanguard · sheet of 5 September 2026
Vanguard · sheet of 5 September 2026ETF sheet · official issuer and register data
Vanguard LifeStrategy 40% Equity UCITS ETF (EUR) Distributing
VNGD40 · IE00BMVB5N38 · EUR · domicile Ireland
Multi-assetactivebond sleeve hedged to EURSFDR art. 6 (inferred)
Comparison benchmark: issuer internal composite (multi-asset)
- TER
- 0.25%+ trans. 0.04%
- Fund size
- 281 m EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 20.74%white list 38.98%
- Replication
- Gestione attiva (dal KID)active management
- Income
- Distributingsemi-annual
Launch 8 Dec 2020 · costs from the KID as of 2 Sept 2026 · 9 securities held · 10 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Fund seeks to provide a combination of income and moderate long term capital appreciation by investing in fixed income and equity securities, primarily through investment in other collective investment schemes. The Fund pursues an actively-managed investment strategy whereby the Investment Manager has discretion over the composition of the Fund's portfolio holdings and is not managed with reference to a benchmark index. However, as more particularly described below, the Investment Manager manages the Fund through pre-determined asset allocations to…
Performance since series start (in euro) — base 100
31 Jan 2021 → 31 Jul 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +9.6% |
| 3 years | +24.8% |
| 5 years | +17.3% |
| 10 years | series too young |
| Since series start | +23.1% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 5.15% | 5.77% | 6.48% |
| Max drawdown | −4.25% | −8.89% | −17.72% |
| Sharpe | 0.61 | 0.33 | -0.29 |
| Sortino | 0.84 | 0.45 | -0.39 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · VNGD40 · IE00BMVB5N381
RebalixVNGD40 · IE00BMVB5N38 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years
Not honestly computable: active management: deviation from the index is management, not replication
Distributions · per share, in EUR
Frequency: semi-annual · last 12 months: 0.7893 EUR (2.92% of NAV) · last ex-date 18 Jun 2026
| Year | Payments | Total (EUR) | Dividend yield |
|---|---|---|---|
| 2026 | 1 | 0.3913 | — |
| 2025 | 2 | 0.7567 | +2.97% |
| 2024 | 2 | 0.7273 | +3.05% |
| 2023 | 2 | 0.626 | +2.81% |
| 2022 | 2 | 0.4942 | +1.85% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 31 Jul 2026 · 9 securities · top-10 weight = 100.0%
| Top holdings | Weight |
|---|---|
| 19.4% | |
| 19.2% | |
| 18.8% | |
| 15.1% | |
| 10.1% | |
| 9.7% | |
| 3.6% | |
| 2.2% | |
| 1.9% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
VNGD40 · Borsa Italiana (ETFplus)
V40D · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Euronext Amsterdam, Tradegate Exchange, Xetra (Deutsche Börse)
+ 10 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
Prospectus · fund-docs.vanguard.com/etf-prospectus-en.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE00BMVB5N38
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BMVB5N38
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · VNGD40 · IE00BMVB5N382